RoutineMetric
Corporate Governance & M&A17 CFR § 240.13e-3

SEC Rule 13e-3 Going-Private Transaction Screener

Evaluate whether a proposed buy-out, squeeze-out, or reverse stock split triggers mandatory Schedule 13E-3 filings under 17 CFR § 240.13e-3. Audit the 8 statutory substantive fairness factors under Regulation M-A Item 1014, size odd-lot fractional share cash-outs to drop below 300 record holders, benchmark against Delaware corporate governance standards under Kahn v. M&F Worldwide (MFW) and In re Match Group (Del. 2024), and generate statutory 30-day regulatory dissemination schedules.

Pre-Configured M&A Deal Presets

1. Statutory Qualification & Filing Person Status

Rule 13e-3(a)(3)(ii) "Going-Private Effect" Tests

2. Valuation, Offer Pricing & Squeeze-Out Sizing

Item 1015 Financial Advisor Fairness Opinion

3. Delaware Fiduciary Safeguards (MFW & In re Match Group 2024)

Special Committee Pillar
Majority-of-Minority Pillar

4. Statutory Regulatory Clock Baseline

SEC Rule 13e-3 StatusMandatory Schedule 13E-3

Subject to SEC Schedule 13E-3 Filing

Mandatory Schedule 13E-3 filing required. The transaction is engaged in by an issuer or affiliate and produces a statutory going-private effect under Rule 13e-3(a)(3)(ii).

Filing Obligation: Both the issuer and each participating affiliate (e.g. PE sponsor and rollover executives) must sign and file Schedule 13E-3 under Section 13(e).
Delaware Standard of ReviewLitigation Risk: Low

Business Judgment Rule (MFW & Match Group Protected)

Both Kahn v. M&F Worldwide (MFW) and In re Match Group (Del. 2024) dual-cleansing prongs satisfied ab initio. Fiduciary challenge subject to dismissal at the pleading stage (Rule 12(b)(6)).

Special Committee: Pristine
Minority Vote: Pristine
Item 1014 Substantive Fairness IndexSEC Comment Risk: LOW
100 / 100
Statutory Valuation Score
Unaffected Spot Premium (29.2%)+20% Target Met
60-Day VWAP Premium (26.5%)Healthy Premium
Net Book Value Multiple (2.27x)Above Book
DCF Going Concern Ratio (1.05x)Fair Value Covered
Liquidation Value Ratio (3.50x)Above Liquidation
2-Year Repurchase High ($ 36.00)Offer ≥ Historical
Fairness OpinionIndependent Opinion

Schedule 13E-3 Statutory Milestone Calendar

Schedule 13E-3 Initial FilingSep 26, 2026

Joint filing on EDGAR with prelim proxy / Schedule TO.

SEC Staff 30-Day Review WindowOct 26, 2026

SEC CorpFin typically issues comments within 30 calendar days.

Definitive 13E-3 DisseminationNov 11, 2026

Mailing of final proxy/tender materials to stockholders.

20-Business-Day ExpirationDec 9, 2026

Mandatory minimum dissemination window under Rule 13e-3(f)(1)(i).

Form 25 & Form 15 FilingDec 20, 2026

Exchange delisting and SEC periodic reporting suspension.

Advertisement
Bottom Banner Ad (728x90)

Navigating SEC Rule 13e-3 Going-Private Transactions: Regulatory Scope, Item 1014 Fairness & Delaware Fiduciary Safeguards

A "going-private" transaction represents one of the most heavily scrutinized transactions under both federal securities regulations and Delaware corporate law. When a public company is acquired by its controlling stockholder, purchased by a private equity sponsor teaming with incumbent management in a management buyout (MBO), or executes a reverse stock split to "go dark," the transaction is governed by Rule 13e-3 of the Securities Exchange Act of 1934 (17 CFR § 240.13e-3). Because insiders and controlling stockholders sit on both sides of the negotiating table, both the Securities and Exchange Commission (SEC) and corporate courts require rigorous substantive disclosure and structural safeguards to protect public unaffiliated stockholders.

1. The Statutory Test: What Triggers SEC Rule 13e-3?

Under Rule 13e-3(a)(3), a transaction is subject to the rule if it meets a two-prong statutory inquiry:

  • The Specified Transaction / Participant Prong: The transaction must involve a purchase of any equity security, a tender offer, or a proxy solicitation/merger by the issuer or by an affiliateof the issuer. An "affiliate" is defined broadly under Rule 12b-2 as any person or entity that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the issuer. In private equity sponsor buyouts where senior management rolls over meaningful equity (typically 10% or more) or secures post-closing executive contracts, the SEC staff routinely treats the buy-side acquisition vehicle as an affiliate, pulling the transaction squarely into Rule 13e-3.
  • The "Going-Private Effect" Prong: The transaction must have either the purpose or a reasonable likelihood of producing, directly or indirectly:
    1. Causing any class of equity securities subject to Section 12(g) or Section 15(d) of the Exchange Act to be held of record by fewer than 300 persons (or fewer than 1,200 persons for bank holding companies); OR
    2. Causing any class of equity securities listed on a national securities exchange (NYSE, Nasdaq) to be delisted.

2. Statutory Exemptions under Rule 13e-3(g)

Even if a transaction produces a going-private effect, certain transactions are exempted from Schedule 13E-3 filing obligations under Rule 13e-3(g):

  • Rule 13e-3(g)(1) (Second-Step Clean-Up Mergers): A second-step merger occurring within one year of the expiration of a tender offer, provided the bidder offered equal or greater consideration than that paid in the tender offer, and the bidder was not an affiliate of the target prior to commencing the tender offer.
  • Rule 13e-3(g)(2) (Registered Equity-for-Equity Rollups): Transactions in which security holders receive only an equity security that is registered under Section 12 or subject to Section 15(d), having substantially similar voting, dividend, and liquidation rights.
  • Rule 13e-3(g)(4) & (g)(6): Routine contractual redemptions pursuant to the governing terms of preferred stock or debt indentures, and corporate reorganizations confirmed by a federal bankruptcy court under Chapter 11.

3. Item 1014 of Regulation M-A: Substantive Fairness Disclosures

The centerpiece of Schedule 13E-3 is Item 1014 of Regulation M-A, which requires each filing person (the issuer, the controlling stockholder, and participating private equity sponsors) to state affirmatively whether they reasonably believe the transaction is fair or unfair to unaffiliated security holders. Crucially, the SEC staff rejects boilerplate assertions of fairness. Instruction 2 to Item 1014 requires a granular, factor-by-factor discussion of 8 statutory valuation benchmarks:

  1. Current Market Price: Premium over current trading prices prior to market rumors.
  2. Historical Market Prices: Analysis of premiums relative to the 30-day, 60-day, and 90-day volume-weighted average price (VWAP) benchmarks.
  3. Net Book Value: Comparison of the offer price to the company's book value per share. If the offer price is below net book value, the filing persons must provide extensive disclosure justifying why the transaction is fair.
  4. Going Concern Value: Discounted cash flow (DCF) models, comparable public companies, and precedent transactions prepared by financial advisors.
  5. Liquidation Value: Net asset recovery value upon orderly liquidation versus going concern value.
  6. Prior Purchase Prices (Item 1002(f)): Prices paid by the issuer or its affiliates in stock purchases or repurchases over the preceding two years. If prior shares were bought at higher prices, the difference must be explained.
  7. Third-Party Firm Offers: Any bona fide acquisition proposals received from unaffiliated third parties over the preceding 18 months.
  8. Procedural Protections: Whether the transaction was negotiated by an independent Special Committee and conditioned on a majority-of-the-minority stockholder vote.

4. Delaware Fiduciary Standards: From MFW to the Landmark Match Group (2024) Ruling

In Delaware, going-private transactions involving controlling stockholders are inherently conflicted and subject to the onerous Entire Fairness standard of judicial review, where defendant directors bear the burden of proving fair dealing and fair price.

In Kahn v. M&F Worldwide Corp. (MFW) (Del. 2014), the Delaware Supreme Court established a safe harbor allowing controlling stockholder freeze-outs to receive deferential review under the Business Judgment Rule (BJR) if, and only if, the controller conditions the buyout ab initio (before economic negotiations begin) upon dual procedural protections:

  • Pillar 1: The negotiation and approval by an independent, fully empowered Special Committeeof directors with its own financial/legal advisors and definitive veto authority ("power to say no"); AND
  • Pillar 2: The uncoerced, fully informed approval by a majority of the unaffiliated minority stockholders.

In April 2024, the Delaware Supreme Court issued its landmark ruling in In re Match Group, Inc. Derivative Litigation (No. 368, 2022). The court resolved years of debate by holding that the dual-protections of MFW apply to all transactions in which a controlling stockholder receives a non-ratable benefit—not just freeze-out squeeze-downs. Most critically:

The Match Group Rule: If a controlling stockholder transaction uses only ONE of the MFW devices (either a Special Committee OR a majority-of-minority vote), the standard of review remains Entire Fairness, with only the burden of proof shifting to the plaintiff. To restore the Business Judgment Rule and achieve early dismissal at the pleading stage, both devices must be perfected ab initio.

5. Micro-Cap "Going Dark" Mechanics: Reverse Stock Splits

For smaller public corporations seeking to eliminate the severe compliance overhead of SEC reporting (Sarbanes-Oxley 404 audits, Form 10-K, Form 10-Q, and EDGAR filings), a common strategy is "going dark" via a reverse/forward stock split (e.g., a 1-for-500 reverse split immediately followed by a 500-for-1 forward split).

Stockholders holding fewer than 500 shares receive cash in lieu of fractional shares, extinguishing their record holder status. If the transaction successfully drives the total number of record holders below 300, the company can file Form 15 with the SEC, immediately suspending its periodic reporting obligations under Sections 12(g) and 15(d). However, because the reverse split produces a going-private effect, the company remains fully subject to Rule 13e-3, requiring a Schedule 13E-3 filing and Item 1014 fairness determinations.

6. Statutory Dissemination Timelines & Regulatory Filing Milestones

Rule 13e-3(f)(1)(i) mandates that Schedule 13E-3 materials must be disseminated to stockholders at least 30 calendar days prior to any stockholder meeting, vote, or security purchase. When conducted via tender offer, the minimum offering period is 20 business daysunder Rule 14e-1. Corporate planners must factor in the SEC staff's standard 30-day review period for preliminary filings, ensuring transaction milestones are sequenced to prevent regulatory hold-ups.

Complementary Utilities

Explore other stateless, logic-driven tools designed for professional workflows.

QuadernoTax Compliance & Automation
Sales Tax & VAT
Instant Nexus Dashboard

Automate Global VAT, GST & US Sales Tax on Every Sale

Calculate real-time statutory taxes, generate tax-compliant invoices, and track economic nexus thresholds automatically.

Discussion & Comments

Join the conversation, ask questions, or share feedback.

Advertisement